We aim to expand our R&D capability
through proactive global partnership activities.

Dong-A ST has consistently pursued domestic and international licensing/partnerships to enhance the strength of our R&D.
To become a global leader, we will actively pursue M&A and open innovation opportunities to secure innovative know-how and technological expertise in new drug development.